Medication on the basis of 3,3′-diindolylmethane (DIM) with high-bioavailability and its use in treatment of human hyperplastic and inflammatory diseases
The invention relates to medicine and chemico-pharmaceutical industry. A medication for treating human hyperplastic and inflammatory diseases containing 3,3′-diindolylmethane as an active agent and a carrier containing a mixture of cod-liver oil and at least one polysorbate at the following proportions of the components in mass %:3,3′-diindolylmethane 1-20cod-liver oil10-20polysorbatethe balance.
